Recruiting Nephrotic Syndrome Studies in Atlanta
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
The goal of the Phase 3a part of this clinical trial is to determine the optimal dose that will be used in the Phase 3b part of this clinical trial. The goal of the Phase 3b part is to assess the effi...
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
To evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN...
About Nephrotic Syndrome Clinical Trials in Atlanta
Nephrotic syndrome is a kidney disorder characterized by heavy proteinuria, low blood albumin, high cholesterol, and swelling. It can be caused by various underlying conditions. Treatment targets the underlying cause and may include immunosuppressive medications and supportive care.
There are currently 2 nephrotic syndrome clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 193 participants. Research is being sponsored by Cerium Pharmaceuticals, Inc., Climb Bio, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Nephrotic Syndrome Clinical Trials in Atlanta — FAQ
Are there nephrotic syndrome clinical trials in Atlanta?
Yes, there are 2 nephrotic syndrome clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Atlanta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.
Are clinical trials in Atlanta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.
What nephrotic syndrome treatments are being tested?
The 2 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for nephrotic syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov